PolyVascular, Inc.
PrivateLast Round
Grant
Apr 24, 2025
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PolyVascular, Inc. is a medical device company that develops minimally invasive, polymeric transcatheter heart valves for children with congenital heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PolyVascular, Inc. Comparables
Compare PolyVascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autus Valve Technologies, Inc. | 93% | |
| PECA Labs, Inc. | 87% | |
| Tremedics Medical Devices | 79% |
PolyVascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 24, 2025 | ||||
| Seed | Aug 29, 2023 | ||||
| Grant | Jul 12, 2023 | ||||
| Grant | Mar 30, 2021 | ||||
| Accelerator | Jun 16, 2020 | ||||
Grant | Mar 8, 2019 |
PolyVascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CobiCure MedTech | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| SWPDC | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 30% MoM.
- May 2, 2025
Monthly visitors grew 88% MoM, reaching 1.1K.
PolyVascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PolyVascular, Inc.'s valuation, stock price, and market status.
Is PolyVascular, Inc. a public or private company?
PolyVascular, Inc. is a private company.
What is the current stock price of PolyVascular, Inc.?
PolyVascular, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is PolyVascular, Inc. worth (valuation)?
Valuation information for PolyVascular, Inc. is not publicly available.
Can I buy PolyVascular, Inc. stock?
PolyVascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PolyVascular, Inc.'s last funding round?
PolyVascular, Inc.'s most recent funding round was Grant on April 24, 2025.
Who are the main investors in PolyVascular, Inc.?
Key investors in PolyVascular, Inc. include CobiCure MedTech, MedTech Innovator, NIH RADx, SWPDC, National Heart, Lung, and Blood Institute.
Will PolyVascular, Inc. IPO soon?
No public IPO plans have been announced for PolyVascular, Inc..
How can I track PolyVascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PolyVascular, Inc.'s secondary market activity and sign up for updates.